Richardson Capital Management’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.15K Sell
27
-75
-74% -$4.07K ﹤0.01% 242
2026
Q1
$6.4K Buy
102
+75
+278% +$6K ﹤0.01% 250
2025
Q4
$2.57K Hold
27
﹤0.01% 205
2025
Q3
$2.64K Sell
27
-7
-21% -$725 ﹤0.01% 213
2025
Q2
$3.65K Hold
34
﹤0.01% 187
2025
Q1
$3.43K Hold
34
﹤0.01% 201
2024
Q4
$3.04K Hold
34
﹤0.01% 133
2024
Q3
$2.85K Hold
34
﹤0.01% 132
2024
Q2
$2.62K Hold
34
﹤0.01% 169
2024
Q1
$2.33K Hold
34
﹤0.01% 136
2023
Q4
$1.97K Buy
+34
New +$1.81K ﹤0.01% 128

Other funds holding BSX

Richardson Capital Management's BSX Position: Q2 2026 in Review

Richardson Capital Management reduced its Boston Scientific (BSX) stake by 74% in Q2 2026, selling an estimated $4.07K and leaving 27 shares worth $1.15K. The position accounts for ﹤0.01% of the portfolio, ranked #242.

Richardson Capital Management first reported a position in BSX in Q4 2023 and has held it in 11 quarters since. The position peaked at $6.4K in Q1 2026. 1,477 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Richardson Capital Management held 27 shares of Boston Scientific worth $1.15K as of Q2 2026.
  • Richardson Capital Management sold 75 Boston Scientific shares in Q2 2026, an estimated $4.07K.
  • Boston Scientific made up ﹤0.01% of Richardson Capital Management's portfolio in Q2 2026, its #242 holding.
  • Richardson Capital Management first reported a position in Boston Scientific in Q4 2023 and has held it in 11 quarters since.
  • Richardson Capital Management's Boston Scientific position peaked at $6.4K in Q1 2026.
  • 1,477 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Richardson Capital Management's 13F filing for Q2 2026, filed 17 Jul 2026.